CoChat

Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation

Open access
Sánchez-Fueyo, Alberto, Whitehouse, Gavin, Grageda, Nathali, Cramp, Matthew E., Lim, Tiong Y., Romano, Marco, Thirkell, Sarah, Lowe, Katie, Fry, Laura, Heward, Julie, Kerr, Alex, Ali, Jakia, Fisher, Chris, Lewis, Gillian, Hope, Andrew, Kodela, Elisavet, Lyne, Mike, Farzaneh, Farzin, Kordasti, Shahram, Rebollo-Mesa, Irene, Jose Lozano, Juan, Safinia, Niloufar, Heaton, Nigel, Lechler, Robert, Martínez-Llordella, Marc, Lombardi, Giovanna · 2020 · American Journal of Transplantation
Cited by 206

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Regulatory T cells (Tregs) are a lymphocyte subset with intrinsic immunosuppressive properties that can be expanded in large numbers ex vivo and have been shown to prevent allograft rejection and promote tolerance in animal models. To investigate the safety, applicability, and biological activity of autologous Treg adoptive transfer in humans, we conducted an open-label, dose-escalation, Phase I clinical trial in liver transplantation. Patients were enrolled while awaiting liver transplantation or 6-12 months posttransplant. Circulating Tregs were isolated from blood or leukapheresis, expanded under good manufacturing practices (GMP) conditions, and administered intravenously at either 0.5-1 million Tregs/kg or 3-4.5 million Tregs/kg. The primary endpoint was the rate of dose- limiting toxicities occurring within 4 weeks of infusion. The applicability of the clinical protocol was poor unless patient recruitment was deferred until 6-12 months posttransplant. Thus, only 3 of the 17 patients who consented while awaiting liver transplantation were dosed. In contrast, all six patients who consented 6-12 months posttransplant received the cell infusion. Treg transfer was safe, transiently increased the pool of circulating Tregs and reduced anti-donor T cell responses. Our study opens the door to employing Treg immunotherapy to facilitate the reduction or complete discontinuation of immunosuppression following liver transplantation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ajt.15700

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 206

Metadata

Authors
Sánchez-Fueyo, A., Whitehouse, G., Grageda, N., Cramp, M. E., Lim, T. Y., Romano, M., Thirkell, S., Lowe, K., Fry, L., Heward, J., Kerr, A., Ali, J., Fisher, C., Lewis, G., Hope, A., Kodela, E., Lyne, M., Farzaneh, F., Kordasti, S., Rebollo-Mesa, I., Jose Lozano, J., Safinia, N., Heaton, N., Lechler, R., Martínez-Llordella, M., & Lombardi, G.
Venue
American Journal of Transplantation
Publisher
Elsevier BV
Published
2020-04
Volume
20
Issue
4
Pages
1125-1136
ISSN
1600-6135 (ISSN-L)
OpenAlex
W2983615744
Cited by
206
References
6
FWCI
7.93
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation. https://app.cochat.ai/papers/10.1111/ajt.15700
The paper
Sánchez-Fueyo, A., Whitehouse, G., Grageda, N., Cramp, M. E., Lim, T. Y., Romano, M., Thirkell, S., Lowe, K., Fry, L., Heward, J., Kerr, A., Ali, J., Fisher, C., Lewis, G., Hope, A., Kodela, E., Lyne, M., Farzaneh, F., Kordasti, S., . . . Lombardi, G. (2020). Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation. American Journal of Transplantation. https://doi.org/10.1111/ajt.15700

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.